Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Consolidated Net Profit

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹260 Cr₹300 Cr₹164 Cr₹64 Cr₹81 Cr

What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?

The latest Consolidated Net Profit ratio of NEULAND LABORATORIES is ₹260 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹260 Cr
Mar2024₹300 Cr
Mar2023₹164 Cr
Mar2022₹64 Cr
Mar2021₹81 Cr

How is Consolidated Net Profit of NEULAND LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹260 Cr
-13.32
Mar2024 ₹300 Cr
83.51
Mar2023 ₹164 Cr
156.21
Mar2022 ₹64 Cr
-20.85
Mar2021 ₹81 Cr -

Compare Consolidated Net Profit of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,423.1 Cr -3.3% -13.5% -3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,147.0 Cr -2.1% -7.7% -9.7% Stock Analytics
DIVIS LABORATORIES ₹161,208.0 Cr -2.6% -6.8% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,190.0 Cr 0.1% 5.5% 25.3% Stock Analytics
CIPLA ₹110,790.0 Cr -1.9% -9.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,587.0 Cr 3.5% -5.2% -11.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-3.3%

-13.5%

-3.5%

SENSEX

-1.3%

-3.1%

6.8%


You may also like the below Video Courses